Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
A brief guide to blue chip alternatives beyond BTC and ETH, highlighting characteristics that define blue chip status and potential rewards.
20,411 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Garmin stock soared this week after the GPS giant posted a solid Q4 and guided higher for 2026. This article breaks d...
Lucid Group has faced years of volatility, but Saudi backing and a clearer product roadmap could shift the odds. This...
A credit card rewards points calculator turns your daily spending into a clear map of value. Learn how to use it, com...
The Supreme Court decision clears a path for roughly $180 billion in tariff refunds to importers, yet Goldman Sachs c...
Public backlash can move beyond headlines and into wallets. This in-depth look examines the financial ripple effects ...
Investors are focusing on the links between battlefield tech and defense earnings as analysts highlight the firearms ...
Tariff headlines keep markets guessing. This guide shows how two Vanguard index funds outperformed the S&P 500 in 202...
Block, the fintech and crypto payments company, is pursuing a major restructuring that could cost up to $500 million ...
A surge in AI and software stocks is driving big, daily swings in CEO wealth even as pay packages grow. Investors oft...
Last year, a surprising shift reshaped the housing market: more than 60% of buyers bought below asking price, marking...
Geopolitical tensions push crypto markets into risk-off mode as XRP faces volatility. This report analyzes price scen...